Depression is the most common psychopathological condition among patients with end-stage renal disease (ESRD), yet it is still under-recognized and misdiagnosed. Depression reduces quality of life and has a negative clinical impact upon sufferers with chronic illness, including ESRD. This article discusses the negative effects of depression among the ESRD population treated with dialysis, the prevalence of the condition, the methodological issues involved with screening and treatment, and the possible psychological and somatic causes. There is a need to identify the prevalence of the disorder by effective methods, overcome the current issues surrounding depression assessment and to undertake trials of suitable treatments.

Keywords:
Depression, End-stage renal disease, Dialysis, Beck depression inventory, Criterion contamination
1.
Kimmel PL: Psychosocial factors in dialysis patients. Kidney Int 2001;59:1599–1613.
2.
Kimmel PL, Weihs K, Peterson RA: Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 1993;4:12–27.
3.
Kimmel PL: Depression in patients with chronic renal disease: what we know and what we need to know. J Psychosom Res 2002;53:951–956.
4.
De-Nour AK, Shaltiel J, Czaczkes JW: Emotional reactions of patients on chronic hemodialysis. Psychosom Med 1968;30:521–533.
5.
O’Brien ME: Compliance behavior and long-term maintenance dialysis. Am J Kidney Dis 1990;15:209–214.
6.
Reiss D: Patient, family, and staff responses to end-stage renal disease. Am J Kidney Dis 1990;15:194–200.
7.
De-Nour AK: Social adjustment of chronic dialysis patients. Am J Psychiatry 1982;139:97–100.
8.
Finkelstein FO, Finkelstein SH: Depression in chronic dialysis patients: assessment and treatment. Nephrol Dial Transplant 2000;15:1911–1913.
9.
Levenson JL, Glocheski S: Psychological factors affecting end-stage renal disease: a review. Psychosomatics 1991;32:382–389.
10.
Watnick S, Wang PL, Demadura T, Ganzini L: Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis 2005;46:919–924.
11.
Killingworth A, van den Akker O: The quality of life of renal dialysis patients: trying to find the missing measurement. Int J Nurs Stud 1996;33:107–120.
12.
Stein MB, Cox BJ, Afifi TO, Belik SL, Sareen J: Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med 2006;36:587–596.
13.
Israel M: Depression in dialysis patients: a review of psychological factors. Can J Psychiatry 1986;31:445–451.
14.
Cummings JL: Depression and Parkinson’s disease: a review. Am J Psychiatry 1992;149:443–454.
15.
Schwab JJ, Bialow M, Brown JM, Holzer CE: Diagnosing depression in medical inpatients. Ann Intern Med 1967;67:695–707.
16.
Klein D, Gittelman R, Quitkin F, et al: Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children, ed 2. Baltimore, Lippincott Williams & Wilkins, 1980.
17.
Koenig HG, George LK, Peterson BL, Pieper CF: Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiatry 1997;154:1376–1383.
18.
Cavanaugh S, Clark DC, Gibbons RD: Diagnosing depression in the hospitalized medically ill. Psychosomatics 1983;24:809–815.
19.
Craven JL, Rodin GM, Johnson L, Kennedy SH: The diagnosis of major depression in renal dialysis patients. Psychosom Med 1987;49:482–492.
20.
Sacks CR, Peterson RA, Kimmel PL: Perception of illness and depression in chronic renal disease. Am J Kidney Dis 1990;15:31–39.
21.
Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH: Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000;57:2093–2098.
22.
Drayer RA, Piraino B, Reynolds CF III, Houck PR, Mazumdar S, Bernardini J, Shear MK, Rollman BL: Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry 2006;28:306–312.
23.
Drayer RA, Mulsant BH, Lenze EJ, Rollman BL, Dew MA, Kelleher K, Karp JF, Begley A, Schulberg HC, Reynolds CF III: Somatic symptoms of depression in elderly patients with medical comorbidities. Int J Geriatr Psychiatry 2005;20:973–982.
24.
Chilcot J, Wellsted DM, Farrington K: Screening for depression while patients dialyze. Nephrology Dialysis Transplantation 2008, in press.
25.
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–3105.
26.
Steptoe A: Depression and Physical Illness. Cambridge, Cambridge University Press, 2006.
27.
Lowry MR, Atcherson E: A short-term follow-up of patients with depressive disorder on entry into home dialysis training. J Affect Disord 1980;2:219–227.
28.
Smith MD, Hong BA, Robson AM: Diagnosis of depression in patients with end-stage renal disease: comparative analysis. Am J Med 1985;79:160–166.
29.
Wuerth D, Finkelstein SH, Ciarcia J, Peterson R, Kliger AS, Finkelstein FO: Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis 2001;37:1011–1017.
30.
Wilson B, Spittal J, Heidenheim P, Herman M, Leonard M, Johnston A, Lindsay R, Moist L: Screening for depression in chronic hemodialysis patients: comparison of the Beck Depression Inventory, primary nurse, and nephrology team. Hemodial Int 2006;10:35–41.
31.
Lopes AA, Albert JM, Young EW, Satayathum S, Pisoni RL, Andreucci VE, Mapes DL, Mason NA, Fukuhara S, Wikstrom B, Saito A, Port FK: Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int 2004;66:2047–2053.
32.
Martin CR, Tweed AE, Metcalfe MS: A psychometric evaluation of the Hospital Anxiety and Depression Scale in patients diagnosed with end-stage renal disease. Br J Clin Psychol 2004;43:51–64.
33.
Boulware LE, Liu Y, Fink NE, Coresh J, Ford DE, Klag MJ, Powe NR: Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol 2006;1:496–504.
34.
Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK: Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002;62:199–207.
35.
Hinrichsen GA, Lieberman JA, Pollack S, Steinberg H: Depression in hemodialysis patients. Psychosomatics 1989;30:284–289.
36.
Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA: The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int 2006;69:1662–1668.
37.
Kalender B, Ozdemir AC, Dervisoglu E, Ozdemir O: Quality of life in chronic kidney disease: effects of treatment modality, depression, malnutrition and inflammation. Int J Clin Pract 2007;61:569–576.
38.
Kim JA, Lee YK, Huh WS, Kim YG, Kim DJ, Oh HY, Kang SA, Kim Moon YH, Kim HW, Kim JH: Analysis of depression in continuous ambulatory peritoneal dialysis patients. J Korean Med Sci 2002;17:790–794.
39.
Martucci M, Balestrieri M, Bisoffi G, Bonizzato P, Covre MG, Cunico L, De Francesso M, Marinoni MG, Mosciaro C, Piccinelli M, Vaccari L, Tansella M: Evaluating psychiatric morbidity in a general hospital: a two-phase epidemiological survey. Psychol Med 1999;29:823–832.
40.
Craven JL, Rodin GM, Littlefield C: The Beck Depression Inventory as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med 1988;18:365–374.
41.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
42.
Kimmel PL, Peterson RA: Depression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs. Semin Dial 2005;18:91–97.
43.
Wulsin LR, Vaillant GE, Wells VE: A systematic review of the mortality of depression. Psychosom Med 1999;61:6–17.
44.
Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112–S119.
45.
Koo JR, Yoon JW, Kim SG, Lee YK, Oh KH, Kim GH, Kim HJ, Chae DW, Noh JW, Lee SK, Son BK: Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis 2003;41:1037–1042.
46.
Knight EL, Ofsthun N, Teng M, Lazarus JM, Curhan GC: The association between mental health, physical function, and hemodialysis mortality. Kidney Int 2003;63:1843–1851.
47.
Irwin M: Immune correlates of depression. Adv Exp Med Biol 1999;461:1–24.
48.
Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Bergmans R, Desnyder R: Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J Affect Disord 1995;36:29–36.
49.
Appels A, Bar FW, Bar J, Bruggeman C, de Baets M: Inflammation, depressive symptomtology, and coronary artery disease. Psychosom Med 2000;62:601–605.
50.
Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH: Immunologic function and survival in hemodialysis patients. Kidney Int 1998;54:236–244.
51.
USRDS: Excerpts from United States Renal Data System 1991 annual data report. Am J Kidney Dis 1991;18:1–127.
52.
Bilgic A, Akgul A, Sezer S, Arat Z, Ozdemir FN, Haberal M: Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr 2007;17:381–388.
53.
Juergensen PH, Wuerth DB, Juergensen DM, Finkelstein SH, Steele TE, Kliger AS, Finkelstein FO: Psychosocial factors and clinical outcome on CAPD. Adv Perit Dial 1997;13:121–124.
54.
Troidle L, Watnick S, Wuerth DB, Gorban-Brennan N, Kliger AS, Finkelstein FO: Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 2003;42:350–354.
55.
Einwohner R, Bernardini J, Fried L, Piraino B: The effect of depressive symptoms on survival in peritoneal dialysis patients. Perit Dial Int 2004;24:256–263.
56.
Kennedy SH, Craven JL, Rodin GM: Major depression in renal dialysis patients: an open trial of antidepressant therapy. J Clin Psychiatry 1989;50:60–63.
57.
Streltzer J: Diagnostic and treatment considerations in depressed dialysis patients. Clin Exp Dial Apheresis 1983;7:257–274.
58.
Shulman R, Price JD, Spinelli J: Biopsychosocial aspects of long-term survival on end-stage renal failure therapy. Psychol Med 1989;19:945–954.
59.
Peterson RA, Kimmel PL, Sacks CR, Mesquita ML, Simmens SJ, Reiss D: Depression, perception of illness and mortality in patients with end-stage renal disease. Int J Psychiatry Med 1991;21:343–354.
60.
Husebye DG, Westlie L, Styrvoky TJ, Kjellstrand CM: Psychological, social, and somatic prognostic indicators in old patients undergoing long-term dialysis. Arch Intern Med 1987;147:1921–1924.
61.
Devins GM, Mann J, Mandin H, Paul LC, Hons RB, Burgess ED, Taub K, Schorr S, Letourneau PK, Buckle S: Psychosocial predictors of survival in end-stage renal disease. J Nerv Ment Dis 1990;178:127–133.
62.
Christensen AJ, Wiebe JS, Smith TW, Turner CW: Predictors of survival among hemodialysis patients: effect of perceived family support. Health Psychol 1994;13:521–525.
63.
Blair-West GW, Cantor CH, Mellsop GW, Eyeson-Annan ML: Lifetime suicide risk in major depression: sex and age determinants. J Affect Disord 1999;55:171–178.
64.
Kurella M, Kimmel PL, Young BS, Chertow GM: Suicide in the United States end-stage renal disease program. J Am Soc Nephrol 2005;16:774–781.
65.
USRDS: USRDS: the United States Renal Data System. Am J Kidney Dis 2003;42:1–230.
66.
Cohen LM, Germain MJ, Poppel DM: Practical considerations in dialysis withdrawal: ‘to have that option is a blessing’. JAMA 2003;289:2113–2119.
67.
Bajwa K, Szabo E, Kjellstrand CM: A prospective study of risk factors and decision making in discontinuation of dialysis. Arch Intern Med 1996;156:2571–2577.
68.
Mailloux LU, Bellucci AG, Napolitano B, Mossey RT, Wilkes BM, Bluestone PA: Death by withdrawal from dialysis: a 20-year clinical experience. J Am Soc Nephrol 1993;3:1631–1637.
69.
Port FK, Wolfe RA, Hawthorne VM, Ferguson CW: Discontinuation of dialysis therapy as a cause of death. Am J Nephrol 1989;9:145–149.
70.
Leggat JE Jr, Bloembergen WE, Levine G, Hulbert-Shearon TE, Port FK: An analysis of risk factors for withdrawal from dialysis before death. J Am Soc Nephrol 1997;8:1755–1763.
71.
McDale-Montez EA, Christensen AJ, Cvengros JA, Lawton WJ: The role of depression symptoms in dialysis withdrawal. Health Psychol 2006;25:198–204.
72.
Ganzini L, Lee MA, Heintz RT, Bloom JD, Fenn DS: The effect of depression treatment on elderly patients’ preferences for life-sustaining medical therapy. Am J Psychiatry 1994;151:1631–1636.
73.
Cohen LM, Germain MJ, Tessier EG: Neuropsychiatric complications and psychopharmacology of end-stage renal disease; in Brady HR, Wilcox CS (eds): Therapy of Nephrology and Hypertension: A Companion to Brenner’s the Kidney. Philadelphia, Elsevier Science, 2003, pp 731–746.
74.
Watnick S, Kirwin P, Mahnensmith R, Concato J: The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis 2003;41:105–110.
75.
Cameron JI, Whiteside C, Katz J, Devins GM: Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 2000;35:629–637.
76.
Gudex CM: Health-related quality of life in endstage renal failure. Qual Life Res 1995;4:359–366.
77.
Zimmermann PR, Poli de Figueiredo CE, Fonseca NA: Depression, anxiety and adjustment in renal replacement therapy: a quality of life assessment. Clin Nephrol 2001;56:387–390.
78.
Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barre PE, Guttmann RD: The emotional impact of end-stage renal disease: importance of patients’ perception of intrusiveness and control. Int J Psychiatry Med 1983;13:327–343.
79.
Wuerth DB, Finkelstein SH, Schwetz O, Carey H, Kliger AS, Finkelstein FO: Patients’ descriptions of specific factors leading to modality selection of chronic peritoneal dialysis or hemodialysis. Perit Dial Int 2002;22:184–190.
80.
Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR: Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 2004;291:697–703.
81.
Kim JA, Lee YK, Huh WS, Kim YG, Kim DJ, Oh HY, Kang SA, Kim Moon YH, Kim HW, Kim JH: Analysis of depression in continuous ambulatory peritoneal dialysis patients. J Korean Med Sci 2002;17:790–794.
82.
Martin CR, Thompson DR: Prediction of quality of life in patients with end-stage renal disease. Br J Health Psychol 2000;5:41–55.
83.
Christensen AJ, Turner CW, Smith TW, Holman JM Jr, Gregory MC: Health locus of control and depression in end-stage renal disease. J Consult Clin Psychol 1991;59:419– 424.
84.
Cvengros JA, Christensen AJ, Lawton WJ: Health locus of control and depression in chronic kidney disease: a dynamic perspective. J Health Psychol 2005;10:677–686.
85.
Taylor SE: Adjustment to threatening events: a theory of cognitive adaptation. Am Psychol 1983;38:1161–1173.
86.
Levy NB: Psychological complications of dialysis: psychonephrology to the rescue. Bull Menninger Clin 1984;48:237–250.
87.
Devins GM, Binik YM, Mandin H, Burgess ED, Taub K, Letourneau PK, Buckle S, Low GL: Denial as a defense against depression in end-stage renal disease: an empirical test. Int J Psychiatry Med 1986;16:151–162.
88.
Capuron L, Ravaud A, Miller AH, Dantzer R: Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun 2004;18:205–213.
89.
Wichers M, Maes M: The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002;5:375–388.
90.
Kimmel PL, Peterson RA, Weihs KL, Shidler N, Simmens SJ, Alleyne S, Cruz I, Yanovski JA, Veis JH, Phillips TM: Dyadic relationship conflict, gender, and mortality in urban hemodialysis patients. J Am Soc Nephrol 2000;11:1518–1525.
91.
Smogorzewski M, Ni Z, Massry SG: Function and metabolism of brain synaptosomes in chronic renal failure. Artif Organs 1995;19:795–800.
92.
Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S: Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003;42:1020–1035.
93.
Kooistra MP, Vos J, Koomans HA, Vos PF: Daily home haemodialysis in the Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998;13:2853–2860.
94.
Heidenheim AP, Muirhead N, Moist L, Lindsay RM: Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003;42:36–41.
95.
Andre MB, Rembold SM, Pereira CM, Lugon JR: Prospective evaluation of an in-center daily hemodialysis program: results of two years of treatment. Am J Nephrol 2002;22:473–479.
96.
Brissenden J, Pierratos A, Ouwendyk M, Roscoe J: Improvements in quality of life with nocturnal hemodialysis (abstract). J Am Soc Nephrol 1998;9:168A.
97.
Reynolds JT, Harding P, Wuerth,D, Finkelstein S, Simon DB, Finkelstein FO: A one year prospective trial of short daily hemodialysis: quality of life (abstract). J Am Soc Nephrol 2001;13:410A.
98.
Keitner GI, Ryan CE, Miller IW, Kohn R, Epstein NB: 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression). Am J Psychiatry 1991;148:345–350.
99.
AHFS: AHFS drug information 2000. Bethesda, American Society of Health-System Pharmacists, 2000.
100.
Whooley MA, Simon GE: Managing depression in medical outpatients. N Engl J Med 2000;343:1942–1950.
101.
Lapid MI, Rummans TA: Evaluation and management of geriatric depression in primary care. Mayo Clin Proc 2003;78:1423–1429.
102.
Wuerth D, Finkelstein SH, Finkelstein FO: The identification and treatment of depression in patients maintained on dialysis. Semin Dial 2005;18:142–146.
103.
Cohen HW, Gibson G, Alderman MH: Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000;108:2–8.
104.
Levy NB, Blumenfield M, Beasley CM Jr, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RR: Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. Gen Hosp Psychiatry 1996;18:8–13.
105.
Christensen AJ, Ehlers SL: Psychological factors in end-stage renal disease: an emerging context for behavioral medicine research. J Consult Clin Psychol 2002;70:712–724.
106.
Hener T, Weisenberg M, Har-Even D: Supportive versus cognitive-behavioral intervention programs in achieving adjustment to home peritoneal kidney dialysis. J Consult Clin Psychol 1996;64:731–741.
107.
Cukor D, Friedman S: Towards the psychosocial treatment of depressed patients on dialysis. Internet J Nephrol 2005, vol 2.
108.
Leake R, Friend R, Wadhwa N: Improving adjustment to chronic illness through strategic self-presentation: an experimental study on a renal dialysis unit. Health Psychol 1999;18:54–62.
109.
Finkelstein FO, Watnick S, Finkelstein SH, Wuerth D: The treatment of depression in patients maintained on dialysis. J Psychosom Res 2002;53:957–960.
110.
Kimura H, Ozaki N: Diagnosis and treatment of depression in dialysis patients. Ther Apher Dial 2006;10:328–332.
111.
Vos PF, Zilch O, Kooistra MP: Clinical outcome of daily dialysis. Am J Kidney Dis 2001;37:S99–S102.
112.
Kurella M, Suri RS, Chertow GM: Frequent hemodialysis and psychosocial function. Semin Dial 2005;18:132–136.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.